Author Archive

Posted 5/7/13 by . Filed under Uncategorized.

Thank you for participating in the 35th Symposium on Biotechnology for Fuel and Chemicals last week in Portland. Our attendance remained strong at over 700 attendees from 29 countries.

EXHIBITORS: Many thanks to our exhibitors for their participation. Our available tables sold out and traffic increased greatly with our new, dedicated, exhibit hours prior to the poster session.

Posted 4/16/13 by . Filed under News and Updates.

SIMB would like to congratulate the winners of the 2013 SIMB Election who will begin their terms of office at the Annual Business Meeting, August 14. Read more about the newly-elected officers here on the 2013 Candidates Bios (PDF).

President-elect
Tim Davies, Ph.D., Green Biologics, Abdington, UK

Directors
Ramon Gonzalez, Ph.D., Rice University, Houston, TX
Debbie Yaver, Novozymes, Davis, CA

Thanks to everyone who participate in this year’s election.

Posted 2/28/13 by . Filed under Uncategorized.

Don’t forget to cast your vote for the 2013 Board of Directors election. The election will close at 3pm EST on March 29, 2013. See what each candidate has to say about their SIMB experience and their outlook for the future. Full bios for each candidate are published in November/December SIMB News as well as on the voting site, and in the linked PDF below. To access the voting site please login to the SIMB members area. If you have not renewed your membership for 2013, renew now to remain eligible to vote.
Reminder: Student members are not eligible to vote.

Download the Election Bios (PDF) to read up on the candidates running this year.

Posted 1/29/13 by . Filed under News and Updates, RAFT X.

RAFT X (Marco Island, FL; November 3-6, 2013) will be an opportunity to look back at 20 years of fermentation and bioprocess development, while looking forward to how our industry and research focus needs to change. More information on the meeting coming soon.

RAFT I was held in 1995, a decade after the first recombinant products from a nascent biotechnology industry entered the market. Large traditional pharmaceutical companies still had thriving natural products groups and were producing secondary metabolites in large bioreactors. Oil was again cheap after the oil embargo of the 70s and the idea of global warming had yet to take hold. The enthusiasm for ethanol and other renewable biochemical industries were still a future dream.